The Development of Dry Eye Disease after Surgery-Indicated Chronic Rhinosinusitis: A Population-Based Cohort Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Ethics Declaration and Data Resource
2.2. Patient Selection
2.3. Main Outcome Measurement
2.4. Demographic Variables and Co-Morbidities
2.5. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Siedek, V.; Stelter, K.; Betz, C.S.; Berghaus, A.; Leunig, A. Functional endoscopic sinus surgery—A retrospective analysis of 115 children and adolescents with chronic rhinosinusitis. Int. J. Pediatr. Otorhinolaryngol. 2009, 73, 741–745. [Google Scholar] [CrossRef]
- Gulati, S.P.; Chaudhry, D.; Kalra, V.; Wadhera, R.; Garg, A. The role of functional endoscopic sinus surgery (fess) in patients with asthma with chronic sinusitis. Indian J. Otolaryngol. Head Neck Surg.: Off. Publ. Assoc. Otolaryngol. India 2008, 60, 152–155. [Google Scholar] [CrossRef] [Green Version]
- Anselmo-Lima, W.T.; Ferreira, M.D.; Valera, F.C.; Rossato, M.; de Mello, V.R.; Demarco, R.C. Histological evaluation of maxillary sinus mucosa after functional endoscopic sinus surgery. Am. J. Rhinol. 2007, 21, 719–724. [Google Scholar] [CrossRef] [PubMed]
- Sedaghat, A.R. Chronic rhinosinusitis. Am. Fam. Physician 2017, 96, 500–506. [Google Scholar] [PubMed]
- Constantin, F.; Niculescu, P.A.; Petre, O.; Balasa, D.; Tunas, A.; Rusu, I.; Lupascu, M.; Orodel, C. Orbital cellulitis and brain abscess—rare complications of maxillo-spheno-ethmoidal rhinosinusitis. Rom. J. Ophthalmol. 2017, 61, 133–136. [Google Scholar] [CrossRef] [PubMed]
- Fokkens, W.J.; Lund, V.J.; Mullol, J.; Bachert, C.; Alobid, I.; Baroody, F.; Cohen, N.; Cervin, A.; Douglas, R.; Gevaert, P.; et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology. 2012, 50, 1–12. [Google Scholar] [CrossRef] [Green Version]
- Tan, B.K.; Lane, A.P. Endoscopic sinus surgery in the management of nasal obstruction. Otolaryngol. Clin. N. Am. 2009, 42, 227–240. [Google Scholar] [CrossRef]
- Ramakrishnan, V.R.; Kennedy, D.W. Advances in the surgical management of chronic sinusitis and nasal polyps. Curr. Allergy Asthma Rep. 2011, 11, 220–229. [Google Scholar] [CrossRef]
- Welch, K.C.; Stankiewicz, J.A. A contemporary review of endoscopic sinus surgery: Techniques, tools, and outcomes. Laryngoscope 2009, 119, 2258–2268. [Google Scholar] [CrossRef]
- Barac, A.; Pekmezovic, M.; Spiric, V.T.; Trivic, A.; Marinkovic, J.; Pekic, S.; Arsenijevic, V.A. Chronic rhinosinusitis: Association of recalcitrant nasal polyposis and fungal finding in polyp’s single-cell suspension. Eur. Arch. Oto-Rhino-Laryngol. 2015, 272, 3727–3734. [Google Scholar] [CrossRef]
- Brooks, S.G.; Trope, M.; Blasetti, M.; Doghramji, L.; Parasher, A.; Glicksman, J.T.; Kennedy, D.W.; Thaler, E.R.; Cohen, N.A.; Palmer, J.N.; et al. Preoperative lund-mackay computed tomography score is associated with preoperative symptom severity and predicts quality-of-life outcome trajectories after sinus surgery. Int. Forum Allergy Rhinol. 2018, 8, 668–675. [Google Scholar] [CrossRef] [PubMed]
- Chang, Y.S.; Chen, P.L.; Hung, J.H.; Chen, H.Y.; Lai, C.C.; Ou, C.Y.; Chang, C.M.; Wang, C.K.; Cheng, H.C.; Tseng, S.H. Orbital complications of paranasal sinusitis in taiwan, 1988 through 2015: Acute ophthalmological manifestations, diagnosis, and management. PLoS ONE 2017, 12, e0184477. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Nejabat, M.; Mahmoudi Nezhad, G.S.; Shenavandeh, S.; Ashraf, M.J.; Jalalpour, M.H. Conjunctivitis as a manifestation of wegener’s granulomatosis. J. Curr. Ophthalmol. 2018, 30, 268–272. [Google Scholar] [CrossRef] [PubMed]
- Tsubota, K.; Yokoi, N.; Shimazaki, J.; Watanabe, H.; Dogru, M.; Yamada, M.; Kinoshita, S.; Kim, H.M.; Tchah, H.W.; Hyon, J.Y.; et al. New perspectives on dry eye definition and diagnosis: A consensus report by the asia dry eye society. Ocul. Surf. 2017, 15, 65–76. [Google Scholar] [CrossRef] [PubMed]
- Milner, M.S.; Beckman, K.A.; Luchs, J.I.; Allen, Q.B.; Awdeh, R.M.; Berdahl, J.; Boland, T.S.; Buznego, C.; Gira, J.P.; Goldberg, D.F.; et al. Dysfunctional tear syndrome: Dry eye disease and associated tear film disorders—New strategies for diagnosis and treatment. Curr. Opin. Ophthalmol. 2017, 28 (Suppl. 1), 3–47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Crombruggen, K.; Zhang, N.; Gevaert, P.; Tomassen, P.; Bachert, C. Pathogenesis of chronic rhinosinusitis: Inflammation. J. Allergy Clin. Immunol. 2011, 128, 728–732. [Google Scholar] [CrossRef]
- Gurrola, J., 2nd; Borish, L. Chronic rhinosinusitis: Endotypes, biomarkers, and treatment response. J. Allergy Clin. Immunol. 2017, 140, 1499–1508. [Google Scholar] [CrossRef]
- Stevens, W.W.; Lee, R.J.; Schleimer, R.P.; Cohen, N.A. Chronic rhinosinusitis pathogenesis. J. Allergy Clin. Immunol. 2015, 136, 1442–1453. [Google Scholar] [CrossRef] [Green Version]
- Olcott, C.M.; Han, J.K.; Cunningham, T.D.; Franzese, C.B. Interleukin-9 and interleukin-17c in chronic rhinosinusitis. Int. Forum Allergy Rhinol. 2016, 6, 841–847. [Google Scholar] [CrossRef]
- Homma, T.; Kato, A.; Sakashita, M.; Takabayashi, T.; Norton, J.E.; Suh, L.A.; Carter, R.G.; Harris, K.E.; Peters, A.T.; Grammer, L.C.; et al. Potential involvement of the epidermal growth factor receptor ligand epiregulin and matrix metalloproteinase-1 in pathogenesis of chronic rhinosinusitis. Am. J. Respir. Cell Mol. Biol. 2017, 57, 334–345. [Google Scholar] [CrossRef]
- Chowdhury, N.I.; Chandra, R.K.; Li, P.; Ely, K.; Turner, J.H. Investigating the correlation between mucus cytokine levels, inflammatory cell counts, and baseline quality-of-life measures in chronic rhinosinusitis. Int. Forum Allergy Rhinol. 2019, 9, 538–544. [Google Scholar] [CrossRef]
- Chhadva, P.; Goldhardt, R.; Galor, A. Meibomian gland disease: The role of gland dysfunction in dry eye disease. Ophthalmology 2017, 124, S20–s26. [Google Scholar] [CrossRef] [PubMed]
- Stapleton, F.; Alves, M.; Bunya, V.Y.; Jalbert, I.; Lekhanont, K.; Malet, F.; Na, K.S.; Schaumberg, D.; Uchino, M.; Vehof, J.; et al. Tfos dews ii epidemiology report. Ocul. Surf. 2017, 15, 334–365. [Google Scholar] [CrossRef]
- Liu, R.; Gao, C.; Chen, H.; Li, Y.; Jin, Y.; Qi, H. Analysis of th17-associated cytokines and clinical correlations in patients with dry eye disease. PLoS ONE 2017, 12, e0173301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kohanski, M.A.; Reh, D.D. Chapter 11: Granulomatous diseases and chronic sinusitis. Am. J. Rhinol. Allergy 2013, 27 (Suppl. 1), S39–S41. [Google Scholar] [CrossRef]
- Mathews, P.M.; Hahn, S.; Hessen, M.; Kim, J.; Grader-Beck, T.; Birnbaum, J.; Baer, A.N.; Akpek, E.K. Ocular complications of primary sjogren syndrome in men. Am. J. Ophthalmol. 2015, 160, 447–452.e441. [Google Scholar] [CrossRef] [PubMed]
- DeConde, A.S.; Soler, Z.M. Chronic rhinosinusitis: Epidemiology and burden of disease. Am. J. Rhinol. Allergy 2016, 30, 134–139. [Google Scholar] [CrossRef]
- Wu, M.; Liu, X.; Han, J.; Shao, T.; Wang, Y. Association between sleep quality, mood status, and ocular surface characteristics in patients with dry eye disease. Cornea 2019, 38, 311–317. [Google Scholar] [CrossRef] [PubMed]
- Chen, W.C.; Chang, Y.T.; Chen, S.F.; Lin, W.C.; Su, Y.Y.; Luo, S.D. The symptom burden of autonomic dysfunction is positively associated with chronic rhinosinusitis status. Rhinology 2018, 56, 227–233. [Google Scholar] [CrossRef] [PubMed]
- Yen, J.C.; Hsu, C.A.; Li, Y.C.; Hsu, M.H. The prevalence of dry eye syndrome’s and the likelihood to develop sjogren’s syndrome in taiwan: A population-based study. Int. J. Environ. Res. Public Health 2015, 12, 7647–7655. [Google Scholar] [CrossRef] [Green Version]
- Anwar, Z.; Wellik, S.R.; Galor, A. Glaucoma therapy and ocular surface disease: Current literature and recommendations. Curr. Opin. Ophthalmol. 2013, 24, 136–143. [Google Scholar] [CrossRef] [PubMed]
- Hsu, Y.R.; Huang, J.C.; Tao, Y.; Kaburaki, T.; Lee, C.S.; Lin, T.C.; Hsu, C.C.; Chiou, S.H.; Hwang, D.K. Noninfectious uveitis in the asia-pacific region. Eye (Lond. Engl.) 2019, 33, 66–77. [Google Scholar] [CrossRef]
- Al-Zamil, W.M.; Yassin, S.A. Recent developments in age-related macular degeneration: A review. Clin. Interv. Aging 2017, 12, 1313–1330. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dietz de Loos, D.; Lourijsen, E.S.; Wildeman, M.A.M.; Freling, N.J.M.; Wolvers, M.D.J.; Reitsma, S.; Fokkens, W.J. Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology. J. Allergy Clin. Immunol. 2019, 143, 1207–1214. [Google Scholar] [CrossRef] [PubMed]
Baseline Characteristics | Study N = 6076 | Control N = 24,304 | p Value |
---|---|---|---|
Age | 1.0000 | ||
<40 | 2283 (37.57%) | 9132 (37.57%) | |
40–59 | 2637 (43.4%) | 10,548 (43.4%) | |
60–79 | 1102 (18.14%) | 4408 (18.14%) | |
≥80 | 54 (0.89%) | 216 (0.89%) | |
Gender | 1.0000 | ||
Male | 3914 (64.42%) | 15,656 (64.42%) | |
Female | 2162 (35.58%) | 8648 (35.58%) | |
Co-morbidities | |||
Hypertension | 1597 (26.28%) | 5362 (22.06%) | <0.0001 |
Diabetes mellitus | 797 (13.12%) | 2681 (11.03%) | <0.0001 |
Ischemic heart disease | 592 (9.74%) | 1812 (7.46%) | <0.0001 |
Hyperlipidemia | 1403 (23.09%) | 4443 (18.28%) | <0.0001 |
Heart failure | 214 (3.52%) | 645 (2.65%) | 0.0003 |
Peripheral vascular disease | 159 (2.62%) | 479 (1.97%) | 0.0017 |
Cerebrovascular disease | 410 (6.75%) | 1307 (5.38%) | <0.0001 |
Dementia | 34 (0.56%) | 152 (0.63%) | 0.5563 |
Chronic pulmonary diseases | 1664 (27.39%) | 3833 (15.77%) | <0.0001 |
Rheumatic disease | 138 (2.27%) | 377 (1.55%) | 0.0001 |
Peptic ulcer disease | 1780 (29.3%) | 5177 (21.3%) | <0.0001 |
Liver disease | 1536 (25.28%) | 4519 (18.59%) | <0.0001 |
Hemiplegia or paraplegia | 41 (0.67%) | 227 (0.93%) | 0.0533 |
Keratopathy | 424 (6.98%) | 1277 (5.25%) | <0.0001 |
Uveitis | 56 (0.92%) | 158 (0.65%) | 0.0236 |
Glaucoma | 120 (1.97%) | 335 (1.38%) | 0.0006 |
AMD | 51 (0.84%) | 141 (0.58%) | 0.0226 |
Event | Study n = 6076 | Control n = 24,304 |
---|---|---|
Follow-up person months | 307,691 | 1,260,167 |
New dry eye disease case | 317 | 770 |
Incidence rate * (95% CI) | 103.03 (92.29–115.02) | 61.10 (56.93–65.57) |
Crude Relative risk (95% CI) | 1.685 (1.479–1.921) | Reference |
Variable | aHR (95% CI) |
---|---|
Surgery-indicated CRS | 1.490 (1.303–1.702) |
Age (Reference:40–59) | |
<40 | 0.497 (0.420–0.588) |
60–79 | 1.389 (1.194–1.616) |
≥80 | 1.019 (0.548–1.894) |
Gender (Reference: Female) | |
Male | 0.504 (0.447–0.569) |
Co-morbidities | |
Hypertension | 0.994 (0.847–1.166) |
Diabetes mellitus | 1.016 (0.849–1.216) |
Ischemic heart disease | 0.980 (0.802–1.198) |
Hyperlipidemia | 1.143 (0.975–1.339) |
Heart failure | 0.786 (0.573–1.079) |
Peripheral vascular disease | 1.683 (1.278–2.217) |
Cerebrovascular disease | 1.028 (0.820–1.290) |
Dementia | 0.740 (0.363–1.505) |
Chronic pulmonary diseases | 1.221 (1.058–1.409) |
Rheumatic disease | 1.212 (0.876–1.677) |
Peptic ulcer disease | 1.547 (1.353–1.770) |
Liver disease | 1.191 (1.031–1.376) |
Hemiplegia or paraplegia | 0.892 (0.485–1.639) |
Keratopathy | 2.300 (1.907–2.773) |
Uveitis | 1.664 (1.049–2.639) |
Glaucoma | 2.132 (1.582–2.873) |
AMD | 1.620 (1.005–2.611) |
Subgroups | Incidence Rate (95% CI) | aHR (95% CI) | |
---|---|---|---|
Study | Control | ||
Gender | |||
Male | 71.29 (60.55–83.94) | 43.89 (39.58–48.67) | 1.418 (1.165–1.726) |
Female | 163.63 (140.98–189.93) | 93.18 (84.58–102.65) | 1.580 (1.316–1.897) |
p for interaction | 0.6765 | ||
Age | |||
<40 | 163.63 (140.98–189.93) | 93.18 (84.58–102.65) | 1.368 (0.997-–1.878) |
40–59 | 124.55 (106.97–145.02) | 65.54 (59.12–72.65) | 1.670 (1.383–2.018) |
60–79 | 192.26 (156.89–235.59) | 127.17 (112.43–143.85) | 1.329 (1.042–1.694) |
≥80 | 260.77 (97.87–694.80) | 92.97 (44.32–195.02) | 9.196 (1.153–73.357) |
p for interaction | 0.3170 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lee, C.-Y.; Yang, K.-L.; Sun, C.-C.; Huang, J.-Y.; Chen, H.-C.; Chen, H.-C.; Yang, S.-F. The Development of Dry Eye Disease after Surgery-Indicated Chronic Rhinosinusitis: A Population-Based Cohort Study. Int. J. Environ. Res. Public Health 2020, 17, 3829. https://doi.org/10.3390/ijerph17113829
Lee C-Y, Yang K-L, Sun C-C, Huang J-Y, Chen H-C, Chen H-C, Yang S-F. The Development of Dry Eye Disease after Surgery-Indicated Chronic Rhinosinusitis: A Population-Based Cohort Study. International Journal of Environmental Research and Public Health. 2020; 17(11):3829. https://doi.org/10.3390/ijerph17113829
Chicago/Turabian StyleLee, Chia-Yi, Kun-Lin Yang, Chi-Chin Sun, Jing-Yang Huang, Hung-Chih Chen, Hung-Chi Chen, and Shun-Fa Yang. 2020. "The Development of Dry Eye Disease after Surgery-Indicated Chronic Rhinosinusitis: A Population-Based Cohort Study" International Journal of Environmental Research and Public Health 17, no. 11: 3829. https://doi.org/10.3390/ijerph17113829